Related references
Note: Only part of the references are listed.The coding capacity of SARS-CoV-2
Yaara Finkel et al.
NATURE (2021)
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response
Zengguo Cao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Opposing activities of IFITM proteins in SARS-CoV-2 infection
Guoli Shi et al.
EMBO JOURNAL (2021)
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Tamara S. Rodrigues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Structural insights into SARS-CoV-2 proteins
Rimanshee Arya et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
Ioanna-Evdokia Galani et al.
NATURE IMMUNOLOGY (2021)
Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation
Christopher P. Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production
Keli Chen et al.
VIRUSES-BASEL (2021)
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
Jing-wen Lin et al.
CELL HOST & MICROBE (2021)
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity
Daisy A. Hoagland et al.
IMMUNITY (2021)
SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells
Antoine Rebendenne et al.
JOURNAL OF VIROLOGY (2021)
SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
Jing Wu et al.
CELL REPORTS (2021)
Sarbecovirus ORF6 proteins hamper induction of interferon signaling
Izumi Kimura et al.
CELL REPORTS (2021)
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
Jessica K. Fiege et al.
PLOS PATHOGENS (2021)
Nebulised interferon beta-1a for patients with COVID-19 Comment
Nathan Peiffer-Smadja et al.
LANCET RESPIRATORY MEDICINE (2021)
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Jordan J. Feld et al.
LANCET RESPIRATORY MEDICINE (2021)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Phillip D. Monk et al.
LANCET RESPIRATORY MEDICINE (2021)
Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids
Shashi Kant Tiwari et al.
STEM CELL REPORTS (2021)
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway
Xiaoyuan Lin et al.
ISCIENCE (2021)
RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
Taisho Yamada et al.
NATURE IMMUNOLOGY (2021)
SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98
Amin Addetia et al.
MBIO (2021)
Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions
Xiaopan Gao et al.
NATURE COMMUNICATIONS (2021)
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
Manuel Hayn et al.
CELL REPORTS (2021)
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity
GuanQun Liu et al.
NATURE MICROBIOLOGY (2021)
Pharmacological activation of STING blocks SARS-CoV-2 infection
Minghua Li et al.
SCIENCE IMMUNOLOGY (2021)
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms
Christine Vazquez et al.
PLOS ONE (2021)
Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
Jack Chun-Chieh Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Noncanonical Functions and Cellular Dynamics of the Mammalian Signal Recognition Particle Components
Camilla Faoro et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response
Yu-Zhi Fu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
Matthew Hackbart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
He-wei Jiang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
LY6E impairs coronavirus fusion and confers immune control of viral disease
Stephanie Pfaender et al.
NATURE MICROBIOLOGY (2020)
The molecular virology of coronaviruses
Ella Hartenian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Benjamin Israelow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Abigail Vanderheiden et al.
JOURNAL OF VIROLOGY (2020)
LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2
Xuesen Zhao et al.
JOURNAL OF VIROLOGY (2020)
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
Abhik K. Banerjee et al.
CELL (2020)
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Donghyuk Shin et al.
NATURE (2020)
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol
Shaobo Wang et al.
EMBO JOURNAL (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Matthias Thoms et al.
SCIENCE (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
Activation and evasion of type I interferon responses by SARS-CoV-2
Xiaobo Lei et al.
NATURE COMMUNICATIONS (2020)
Structural basis of RNA cap modification by SARS-CoV-2
Thiruselvam Viswanathan et al.
NATURE COMMUNICATIONS (2020)
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
Megan L. Stanifer et al.
CELL REPORTS (2020)
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2020)
Animal models for COVID-19
Cesar Munoz-Fontela et al.
NATURE (2020)
SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
Katharina Schubert et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Lisa Miorin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
David E. Gordon et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
High-resolution structures of the SARS-CoV-2 2′-O-methyltransferase reveal strategies for structure-based inhibitor design
Monica Rosas-Lemus et al.
SCIENCE SIGNALING (2020)
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans
Rayhane Nchioua et al.
MBIO (2020)
Evasion of Type I Interferon by SARS-CoV-2
Hongjie Xia et al.
CELL REPORTS (2020)
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
Yoriyuki Konno et al.
CELL REPORTS (2020)
SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
Jingfang Mu et al.
CELL DISCOVERY (2020)
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
Shuai Yuan et al.
MOLECULAR CELL (2020)
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
Steffen Klein et al.
NATURE COMMUNICATIONS (2020)
Viral RNA recognition by LGP2 and MDA5, and activation of signaling through step-by-step conformational changes
Ivana Duic et al.
NUCLEIC ACIDS RESEARCH (2020)
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Chun-Kit Yuen et al.
EMERGING MICROBES & INFECTIONS (2020)
Differential Regulation of Type I and Type III Interferon Signaling
Megan L. Stanifer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
Kam-Leung Siu et al.
FASEB JOURNAL (2019)
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Adriana Forero et al.
IMMUNITY (2019)
Concerted 2-5A-Mediated mRNA Decay and Transcription Reprogram Protein Synthesis in the dsRNA Response
Sneha Rath et al.
MOLECULAR CELL (2019)
RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions
Johannes Schwerk et al.
NATURE IMMUNOLOGY (2019)
ISG15 in antiviral immunity and beyond
Yi-Chieh Perng et al.
NATURE REVIEWS MICROBIOLOGY (2018)
TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
Cynthia Louis et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
Ioanna E. Galani et al.
IMMUNITY (2017)
The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination
Yong Hu et al.
JOURNAL OF VIROLOGY (2017)
Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut
Kalliopi Pervolaraki et al.
FRONTIERS IN IMMUNOLOGY (2017)
IFN is a potent anti-influenza therapeutic without the inflammatory side effects of IFN treatment
Sophia Davidson et al.
EMBO MOLECULAR MEDICINE (2016)
Shutoff of Host Gene Expression in Influenza A Virus and Herpesviruses: Similar Mechanisms and Common Themes
Hembly G. Rivas et al.
VIRUSES-BASEL (2016)
MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus
Zachary B. Zalinger et al.
JOURNAL OF VIROLOGY (2015)
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Siqi Liu et al.
SCIENCE (2015)
Innate immune restriction and antagonism of viral RNA lacking 2′-O methylation
Jennifer L. Hyde et al.
VIROLOGY (2015)
Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain
Kam-Leung Siu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
Anna M. Mielech et al.
VIROLOGY (2014)
Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
Vineet D. Menachery et al.
VIRUS RESEARCH (2014)
Molecular control of the NEMO family of ubiquitin-binding proteins
Kristopher Clark et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus
Jacob S. Yount et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
RNA 3′-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex
Mickael Bouvet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
Roland Zuest et al.
NATURE IMMUNOLOGY (2011)
Tom70 mediates activation of interferon regulatory factor 3 on mitochondria
Xin-Yi Liu et al.
CELL RESEARCH (2010)
2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
Stephane Daffis et al.
NATURE (2010)
Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus
Martin Schlee et al.
IMMUNITY (2009)
The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon
Chen Wang et al.
NATURE IMMUNOLOGY (2009)
The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor
Rinki Minakshi et al.
PLOS ONE (2009)
5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I
Andreas Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5
Hiroki Kato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia
Jessica K. Roth-Cross et al.
JOURNAL OF VIROLOGY (2008)
Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C
Tao Wang et al.
VIROLOGY (2008)
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic Reticulum/Golgi membrane
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2007)
Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions
Mohammad A. Khan et al.
RETROVIROLOGY (2007)
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
Michaela U. Gack et al.
NATURE (2007)
Viral infections activate types I and III interferon genes through a common mechanism
Kazuhide Onoguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The NEMO adaptor bridges the nuclear factor-kappa B and interferon regulatory factor signaling pathways
Tiejun Zhao et al.
NATURE IMMUNOLOGY (2007)
Share Paper
